CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- 8-K Event Executive or director change
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at $4.31 ($43,140)
- 4 Open-market buy Chief Medical Officer bought 10,000 shares at $4.22 ($42,200)
- 8-K Event Regulation FD disclosure · Other events
- S-3ASR Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Shares withheld for taxes Chief Scientific Officer gave up 2,375 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 2,364 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 8,422 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 2,183 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 2,183 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 7,658 shares (to pay taxes)
Page 13 of 74 · 1,467 filings